Diabetes and periodontal disease

International Dental Journal

Volumn 58, Issue 4 SUPPL. 1, 2008, Pages 237-243

  Preshaw, Philip M ^a,b  

^a Newcastle University ^*

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Diabetes complications; Periodontal diseases; Risk factors; Type 1 diabetes mellitus; Type 2 diabetes mellitus

Indexed keywords

EID: 50149087511     PISSN: 00206539     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1875-595x.2008.tb00203.x     Document Type: Conference Paper

References (52)

1. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001 414: 782-787.
2. Diamond J. The double puzzle of diabetes. Nature 2003 423: 599-602.
3. Fiske J. Diabetes mellitus and oral care. Dent Update 2004 31: 190-198.
4. Löe H. Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care 1993 16: 329-334.
5. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003 26: S5-20.
6. Wassail RR, Preshaw PM. Type 2 diabetes mellitus as a risk factor for periodontal disease. PERIO 2006 3: 242-252.
7. Nelson RG, Shlossman M, Budding LM, et al. Periodontal disease and NIDDM in Pima Indians. Diabetes Care 1990 13: 836-840.
8. Taylor GW, Burt BA, Becker MP, et al. Non-insulin dependent diabetes mellitus and alveolar bone loss progression over 2 years. J Periodontal 1998 69: 76-83.
9. Emrich LJ, Shlossman M, Genco RJ. Periodontal disease in non-insulin dependent diabetes mellitus. J Periodontal 1991 62: 123-131.
10. Sandberg GE, Sundberg HE, Fjellstrom CA, et al. Type 2 diabetes and oral health: a comparison between diabetic and non-diabetic subjects. Diabetes Res Clin Pract 2000 50: 27-34.
11. Jansson H, Lindholm E, Lindh C, et al. Type 2 diabetes and risk for periodontal disease: a role for dental health awareness. J Clin Periodontal 2006 33: 408-414.
12. Tervonen T, Karjalainen K, Knuuttila M, et al. Alveolar bone loss in type 1 diabetic subjects. J Clin Periodontal 2000 27: 567-571.
13. Lalla E, Cheng B, Lai S, et al. Diabetes mellitus promotes periodontal destruction in children. J Clin Periodontal 2007 34: 294-298.
14. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005 366: 1809-1820.
15. Freeman DJ, Norrie J, Caslake MJ, et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 2002 51: 1596-1600.
16. Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 2004 25: 4-7.
17. Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein, inter-leukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001 286: 327-334.
18. Trayhurn P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. P Nutr Soc 2001 60: 329-339.
19. Sanchez-Margalet V, Martin-Romero C, Santos-Alvarez J, et al. Role of leptin as an immunomodulator of blood mononuclear cells: mechanisms of action. Clin Exp Immunol 2003 133: 11-19.
20. Otero M, Lago R, Gomez R, et al. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 2006 65: 1198-1201.
21. Munzberg H, Myers MG, Jr. Molecular and anatomical determinants of central leptin resistance. Nature Neuroscience 2005 8: 566-570.
22. McNeely MJ, Boyko EJ, Weigle DS, et al. Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans. Diabetes Care 1999 22: 65-70.
23. Johnson RB, Serio FG. Leptin within healthy and diseased human gingiva. J Periodontal 2001 72: 1254-1257.
24. Preshaw PM, Foster N, Taylor JJ. Cross-susceptibility between periodontal disease and type 2 diabetes mellitus: an immunobiological perspective. Periodontal 2000 2007 45: 138-157.
25. Lau DC, Dhillon B, Yan H, et al. Adipokines: molecular links between obesity and atherosclerosis. Am J Physiol Heart Circ Physiol 2005 288: H2031-2041.
26. Noack B, Genco RJ, Trevisan M, et al. Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontal 2001 72: 1221-1227.
27. D'Aiuto F, Parkar M, Andreou G, et al. Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res 2004 83: 156-160.
28. Cutler CW, Machen RL, Jotwani R, et al. Heightened gingival inflammation and attachment loss in type 2 diabetics with hyper-lipidemia. J Periodontal 1999 70: 1313-1321.
29. Engebretson SP, Hey-Hadavi J, Ehrhardt FJ, et al. Gingival crevicular fluid levels of interleukin-1beta and glycemic control in patients with chronic periodontitis and type 2 diabetes. J Periodontal 2004 75: 1203-1208.
30. Navarro-Sanchez AB, Faria-Almeida R, Bascones-Martinez A. Effect of non-surgical periodontal therapy on clinical and immunological response and glycaemic control in type 2 diabetic patients with moderate periodontitis. J Clin Periodontal 2007 34: 835-843.
31. Ruan H, Lodish HF. Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha. Cytokine Growth F R 2003 14: 447-455.
32. Senn JJ, Klover PJ, Nowak IA, et al. Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J Biol Chem 2003 278: 13740-13746.
33. Mowat A, Baum J. Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. N Engl J Med 1971 284: 621-627.
34. Bagdade JD, Stewart M, Walters E. Impaired granulocyte adherence. A reversible defect in host defense in patients with poorly controlled diabetes. Diabetes 1978 27: 677-681.
35. Marhoffer W, Stein M, Maeser E, et al. Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes. Diabetes Care 1992 15: 256-260.
36. Manouchehr-Pour M, Spagnuolo PJ, Rodman HM, et al. Impaired neutrophil chemotaxis in diabetic patients with severe periodontitis. J Dent Res 1981 60: 729-730.
37. Bissada NF, Manouchehr-Pour M, Haddow M, et al. Neutrophil functional activity in juvenile and adult onset diabetic patients with mild and severe periodontitis. J Periodontal Res 1982 17: 500-502.
38. Graves DT, Liu R, Alikhani M, et al. Diabetes-enhanced inflammation and apoptosis - impact on periodontal pathology. J Dent Res 2006 85: 15-21.
39. Tennenberg SD, Finkenauer R, Dwivedi A. Absence of lipopoly-saccharide- induced inhibition of neutrophil apoptosis in patients with diabetes. Arch Surg 1999 134: 1229-1233.
40. Takeda M, Ojima M, Yoshioka H, et al. Relationship of serum advanced glycation end products with deterioration of periodontitis in type 2 diabetes patients. J Periodontal 2006 77: 15-20.
41. Lalla E, Lamster IB, Stern DM, et al. Receptor for advanced glycation end products, inflammation, and accelerated periodontal disease in diabetes: mechanisms and insights into therapeutic modalities. Ann Periodontal 2001 6: 113-118.
42. Salvi GE, Collins JG, Yalda B, et al. Monocytic TNF alpha secretion patterns in IDDM patients with periodontal diseases. J Clin Periodontal 1997 24: 8-16.
43. Vlassara H. The AGE-receptor in the pathogenesis of diabetic complications. Diabetes Metab Res 2001 17: 436-443.
44. Wong RK, Pettit AI, Quinn PA, et al. Advanced glycation end products stimulate an enhanced neutrophil respiratory burst mediated through the activation of cytosolic phospholipase A2 and generation of arachidonic Acid. Circulation 2003 108: 1858-1864.
45. Janket SJ, Wightman A, Baird AE, et al. Does periodontal treatment improve glycemic control in diabetic patients? A meta-analysis of intervention studies. J Dent Res 2005 84: 1154-1159.
46. Marshall-Day CD, Stephens RG, Quigley LF. Periodontal disease: prevalence and incidence. J Periodontal 1955 26: 185-203.
47. Brown LJ, Brunelle JA, Kingman A. Periodontal status in the United States, 1988-1991: prevalence, extent, and demographic variation. J Dent Res 1996 75 Spec Iss: 672-683.
48. Kelly M, Steele J, Nuttall N, et al, The condition of supporting structures, in Adult dental health survey. Oral health in the United Kingdom 1998, A. Walker and I. Cooper, Editors. 2000, The Stationery Office: London. p. 123-146.
49. Hujoel PP, del Aguila MA, DeRouen TA, et al. A hidden periodontitis epidemic during the 20th century? Community Dent Oral Epidemiol 2003 31: 1-6.
50. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998 21: 1414-1431.
51. Ismail AA, BeechingNJ, Gill GV, et al. Capture-recapture-adjusted prevalence rates of type 2 diabetes are related to social deprivation. QJM 1999 92: 707-710.
52. Evans JM, Newton RW, Ruta DA, et al. Socio-economic status, obesity and prevalence of Type 1 and Type 2 diabetes mellitus. Diabet Med 2000 17: 478-480.